TY - JOUR
T1 - 4E-BP2/SH2B1/IRS2 are part of a novel feedback loop that controls β-cell mass
AU - Blandino-Rosano, Manuel
AU - Scheys, Joshua O.
AU - Jimenez-Palomares, Margarita
AU - Barbaresso, Rebecca
AU - Bender, Aaron S.
AU - Yanagiya, Akiko
AU - Liu, Ming
AU - Rui, Liangyou
AU - Sonenberg, Nahum
AU - Bernal-Mizrachi, Ernesto
N1 - Publisher Copyright:
© 2016 by the American Diabetes Association.
PY - 2016/8/1
Y1 - 2016/8/1
N2 - The mammalian target of rapamycin complex 1 (mTORC1) regulates several biological processes, although the key downstream mechanisms responsible for these effects are poorly defined. Using mice with deletion of eukaryotic translation initiation factor 4E-binding protein 2 (4E-BP2), we determine that this downstream target is a major regulator of glucose homeostasis and β-cell mass, proliferation, and survival by increasing insulin receptor substrate 2 (IRS2) levels and identify a novel feedback mechanism by which mTORC1 signaling increases IRS2 levels. In this feedback loop, we show that 4E-BP2 deletion induces translation of the adaptor protein SH2B1 and promotes the formation of a complex with IRS2 and Janus kinase 2, preventing IRS2 ubiquitination. The changes in IRS2 levels result in increases in cell cycle progression, cell survival, and β-cell mass by increasing Akt signaling and reducing p27 levels. Importantly, 4E-BP2 deletion confers resistance to cytokine treatment in vitro. Our data identify SH2B1 as a major regulator of IRS2 stability, demonstrate a novel feedback mechanism linking mTORC1 signaling with IRS2, and identify 4E-BP2 as a major regulator of proliferation and survival of β-cells.
AB - The mammalian target of rapamycin complex 1 (mTORC1) regulates several biological processes, although the key downstream mechanisms responsible for these effects are poorly defined. Using mice with deletion of eukaryotic translation initiation factor 4E-binding protein 2 (4E-BP2), we determine that this downstream target is a major regulator of glucose homeostasis and β-cell mass, proliferation, and survival by increasing insulin receptor substrate 2 (IRS2) levels and identify a novel feedback mechanism by which mTORC1 signaling increases IRS2 levels. In this feedback loop, we show that 4E-BP2 deletion induces translation of the adaptor protein SH2B1 and promotes the formation of a complex with IRS2 and Janus kinase 2, preventing IRS2 ubiquitination. The changes in IRS2 levels result in increases in cell cycle progression, cell survival, and β-cell mass by increasing Akt signaling and reducing p27 levels. Importantly, 4E-BP2 deletion confers resistance to cytokine treatment in vitro. Our data identify SH2B1 as a major regulator of IRS2 stability, demonstrate a novel feedback mechanism linking mTORC1 signaling with IRS2, and identify 4E-BP2 as a major regulator of proliferation and survival of β-cells.
UR - http://www.scopus.com/inward/record.url?scp=84980325694&partnerID=8YFLogxK
U2 - 10.2337/db15-1443
DO - 10.2337/db15-1443
M3 - Article
C2 - 27217487
AN - SCOPUS:84980325694
SN - 0012-1797
VL - 65
SP - 2235
EP - 2248
JO - Diabetes
JF - Diabetes
IS - 8
ER -